logo
Plus   Neg
Share
Email

Infosys Q1 Profit Increases, Lifts FY Revenue Growth View; Stock Up

Infosys Limited (INFY) reported that its profit attributable to owners of the company for the first-quarter increased to $546 million or $0.13 per share from $534 million or $0.12 per share in the same quarter last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.13 per share for the quarter. Analysts' estimates typically exclude special items.

In Friday pre-Market trade, INFY is trading at $11.09, up $0.38 or 3.55 percent.

"Continuing our objective of improving shareholder returns, we have revised our capital allocation policy upwards to distribute ~ 85% of free cash flows cumulatively over a 5-year period," said Nilanjan Roy, CFO.

Quarterly revenues grew to $3.13 billion from $2.83 billion in the prior year. Analysts expected revenue of $3.08 billion for the quarter.

The company raised its fiscal year 2020 revenue growth guidance to a range of 8.5 percent - 10 percent in constant currency from the estimation of 7.5 percent - 9.5 percent growth.

The company said its current policy is to pay up to 70% of the free cash flow annually by way of dividend and/or buyback. The Board has approved a revised Capital Allocation Policy of the company after taking into consideration the strategic and operational cash requirements.

Effective from Financial year 2020, the company expects to return about 85% of the free cash flow cumulatively over a 5-year period through a combination of semi-annual dividends and/or share buyback and/or special dividends.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla has cut prices of its electric cars in North America following a decline in auto demand during the coronavirus-induced lockdowns. The company is also reducing the prices for its vehicles in China. The luxury electric car maker has reduced the prices for its flagship Model S sedan and the Model X sport utility vehicle by $5,000 each. The U.S. Food and Drug Administration granted approval for Artesunate for Injection 110 mg, powder and solvent for solution to biopharmaceutical company Amivas (US), LLC as the only FDA-approved drug now in the U.S. for the first-line treatment of severe malaria in adult and pediatric patients. It is also the first FDA-approved product that Amivas has introduced to their commercial portfolio. Retail giant Walmart Inc. is entering the fashion resale market through its partnership with thredUP, an online consignment store for second-hand fashion and accessories. The deal will enable Walmart to expand its online fashion offerings. Walmart said that starting Wednesday, customers can browse nearly 750,000 pre-owned items across women's and children's clothing, accessories and footwear.
Follow RTT